Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand–expressing tumor cells

JD Coudert, J Zimmer, E Tomasello, M Cebecauer… - Blood, 2005 - ashpublications.org
Blood, 2005ashpublications.org
NKG2D is an activation receptor that allows natural killer (NK) cells to detect diseased host
cells. The engagement of NKG2D with corresponding ligand results in surface modulation of
the receptor and reduced function upon subsequent receptor engagement. However, it is not
clear whether in addition to modulation the NKG2D receptor complex and/or its signaling
capacity is preserved. We show here that the prolonged encounter with tumor cell-bound,
but not soluble, ligand can completely uncouple the NKG2D receptor from the intracellular …
Abstract
NKG2D is an activation receptor that allows natural killer (NK) cells to detect diseased host cells. The engagement of NKG2D with corresponding ligand results in surface modulation of the receptor and reduced function upon subsequent receptor engagement. However, it is not clear whether in addition to modulation the NKG2D receptor complex and/or its signaling capacity is preserved. We show here that the prolonged encounter with tumor cell-bound, but not soluble, ligand can completely uncouple the NKG2D receptor from the intracellular mobilization of calcium and the exertion of cell-mediated cytolysis. However, cytolytic effector function is intact since NKG2D ligand-exposed NK cells can be activated via the Ly49D receptor. While NKG2D-dependent cytotoxicity is impaired, prolonged ligand exposure results in constitutive interferon γ (IFNγ) production, suggesting sustained signaling. The functional changes are associated with a reduced presence of the relevant signal transducing adaptors DNAX-activating protein of 10 kDa (DAP-10) and killer cell activating receptor-associated protein/DNAX-activating protein of 12 kDa (KARAP/DAP-12). That is likely the consequence of constitutive NKG2D engagement and signaling, since NKG2D function and adaptor expression is restored to normal when the stimulating tumor cells are removed. Thus, the chronic exposure to tumor cells expressing NKG2D ligand alters NKG2D signaling and may facilitate the evasion of tumor cells from NK cell reactions. (Blood. 2005;106:1711-1717)
ashpublications.org